| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.4M | -72.6% |
| SG&A Expense | $7.1M | -38.3% |
| Net Income | -$8.6M | +47.2% |
| EPS (Basic) | -$10.66 | -887.0% |
| EPS (Diluted) | -$10.66 | -625.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -67.7% |
| Current Assets | $5.7M | -57.0% |
| Total Assets | $5.7M | -57.8% |
| Current Liabilities | $2.4M | +99.3% |
| Total Liabilities | $2.4M | +32.1% |
| Stockholders' Equity | $3.4M | -71.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | +59.5% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $0 | +100.0% |